TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by American Cyanamid Company to registration of trade mark application number 785004(5) - CALPLATE- filed in the name of Peter Vanas.
Background
Peter Vanas (the applicant) filed trade mark application for the word mark CALPLATE on 10 February 1999 in respect of 'vitamins' in class 5 of the International Classification of goods and services. The application proceeded to acceptance without objection from this Office. It was advertised as accepted in the Australian Official Journal of Trade Marks of 10 June 1999.
American Cyanamid Company (the opponent) filed a notice of opposition on 9 September 1999, within the time allowed to do so, that listed grounds of opposition under s.57 in relation to ss.41, 42(b), 43 and 44 and also under ss. 58, 59 and 60 of the Trade Marks Act 1995.
Following the service of the evidence in support and the expiration of the time allowed for the applicant's evidence in answer, the opponent requested to be heard in the matter and it came before me in Sydney on 16 November 2000.
The opponent is a company with a particular interest in supplying food supplements to the general population, and markets a calcium supplement under the CALTRATE mark, through its Australian subsidiary, Wyeth Australia Pty Limited. The sales figures, which the opponent has requested remain confidential, show strong sales from 1992 (the first year quoted) to more than double that figure by 1999. Until 1997, the opponent's goods were available only through pharmacy outlets but after that date, non-pharmacy trade channels, such as supermarkets and grocery stores, have also been opened up. The opponent also has three registered trade marks which either contain or consist of the word CALTRATE.
The Evidence
The opponent's evidence supporting its opposition is the single declaration by Stanley J Silverberg. Mr Silverberg is a Senior Trade Mark Attorney for the opponent, in the United States of America. He gives details of the opponent's Australian trade mark registrations and describes trade mark use of CALTRATE throughout Australia, in respect of a range of vitamin and mineral preparations and nutritional supplements. This use dates from 1985. He also provides sales figures for goods sold under the mark during calendar years 1992 to 1999 and advertising expenditure for 1994 to 1999.
Mr Silverberg says (at clause 8) that the trade mark CALTRATE has been 'extensively advertised and promoted throughout Australia in the form of leaflets, information cards, point of sale displays, trade journals (PS Post Script), message pads, book advertisements and magazine advertisements', and he exhibits samples of these under SJS-3.
The applicant did not serve any evidence in answer to the opposition.
Submissions and Discussion
At the hearing, the opponent was represented by Mr Gerard Skelly of Spruson & Ferguson, Patent and Trade Mark Attorneys of Sydney. The applicant chose not to be represented, nor did he provide any submissions in the matter.
At the outset of the…
Keep reading for free
Create a free CaseChat account to read American Cyanamid Company v Peter Vanas and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2001] ATMO 11
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the court was whether the applicants had established a sufficient likelihood of success in their claim of contravention of section 52 of the Trade Practices Act 1974 (Cth) to warrant the grant of interlocutory injunctive relief. This involved considering whether the advertisements and representations made by the respondent were likely to mislead or deceive the relevant class of consumers, and whether the applicants had demonstrated a serious question to be tried.
In determining whether to grant interlocutory relief, the court applied the principles established in *Australian Coarse Grain Pty Ltd v Palmer* and *Beecham Group Ltd v Bristol-Myers Co*. These principles require the court to consider whether there is a serious question to be tried and, if so, to weigh the balance of convenience between the parties. The court examined the content of the advertisements and representations, the nature of the product, and the likely impact on consumers. The court found that the applicants had not established a sufficient likelihood of success on the merits of their claim to justify the grant of interlocutory relief.
The court therefore dismissed the application for interlocutory injunctions.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.